Quantitative Proteomics For Biomarker Discovery and Validation: Prostate Cancer Case StudyWednesday, 18 May 2011 at 14:45 Add to Calendar ▼2011-05-18 14:45:002011-05-18 15:45:00Europe/LondonQuantitative Proteomics For Biomarker Discovery and Validation: Prostate Cancer Case StudyEuropean Biomarkers Summit in LondonLondonSELECTBIOenquiries@selectbiosciences.com There is an important need for clinically relevant biomarkers which will improve the diagnosis and the management of patients with prostate cancer. Here a strategy integrating label-free LC-MS based protein biomarker discovery with subsequent multiplexed validation by multiple reaction monitoring MS that is directed to the development of biomarkers of clinical utility for prostate cancer will be described. |